JP2023533849A5 - - Google Patents

Info

Publication number
JP2023533849A5
JP2023533849A5 JP2023502861A JP2023502861A JP2023533849A5 JP 2023533849 A5 JP2023533849 A5 JP 2023533849A5 JP 2023502861 A JP2023502861 A JP 2023502861A JP 2023502861 A JP2023502861 A JP 2023502861A JP 2023533849 A5 JP2023533849 A5 JP 2023533849A5
Authority
JP
Japan
Application number
JP2023502861A
Other languages
Japanese (ja)
Other versions
JP2023533849A (ja
JP7686741B2 (ja
JPWO2022013307A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/069649 external-priority patent/WO2022013307A1/en
Publication of JP2023533849A publication Critical patent/JP2023533849A/ja
Publication of JP2023533849A5 publication Critical patent/JP2023533849A5/ja
Publication of JPWO2022013307A5 publication Critical patent/JPWO2022013307A5/ja
Application granted granted Critical
Publication of JP7686741B2 publication Critical patent/JP7686741B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502861A 2020-07-15 2021-07-14 Alk5阻害剤としてのピリダジニルアミノ誘導体 Active JP7686741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20185890.9 2020-07-15
EP20185890 2020-07-15
PCT/EP2021/069649 WO2022013307A1 (en) 2020-07-15 2021-07-14 Pyridazinyl amino derivatives as alk5 inhibitors

Publications (4)

Publication Number Publication Date
JP2023533849A JP2023533849A (ja) 2023-08-04
JP2023533849A5 true JP2023533849A5 (https=) 2024-07-22
JPWO2022013307A5 JPWO2022013307A5 (https=) 2024-07-22
JP7686741B2 JP7686741B2 (ja) 2025-06-02

Family

ID=71620257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502861A Active JP7686741B2 (ja) 2020-07-15 2021-07-14 Alk5阻害剤としてのピリダジニルアミノ誘導体

Country Status (19)

Country Link
US (1) US12479826B2 (https=)
EP (1) EP4182308B1 (https=)
JP (1) JP7686741B2 (https=)
KR (1) KR20230051500A (https=)
CN (1) CN116096719B (https=)
AR (1) AR122986A1 (https=)
AU (1) AU2021307559A1 (https=)
BR (1) BR112023000588A8 (https=)
CA (1) CA3184990A1 (https=)
DK (1) DK4182308T3 (https=)
ES (1) ES2997111T3 (https=)
FI (1) FI4182308T3 (https=)
HR (1) HRP20241617T1 (https=)
HU (1) HUE069150T2 (https=)
MX (1) MX2023000521A (https=)
PL (1) PL4182308T3 (https=)
PT (1) PT4182308T (https=)
SI (1) SI4182308T1 (https=)
WO (1) WO2022013307A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7702205B2 (ja) * 2021-09-15 2025-07-03 株式会社東芝 新規アミン化合物、酸性ガス吸収剤、酸性ガスの除去方法及び酸性ガス除去
CN114957331A (zh) * 2022-04-22 2022-08-30 北京康辰药业股份有限公司 磷酸酯取代的环丙酰胺衍生喹唑啉类化合物的制备方法
WO2024180206A1 (en) 2023-03-02 2024-09-06 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
WO2024180207A1 (en) 2023-03-02 2024-09-06 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
KR20240159754A (ko) * 2023-04-28 2024-11-06 한국원자력의학원 N-메틸피페라진 에탄올 카바메이트(N-methylpiperazine ethanol carbamate) 구조를 포함하는 신규 화합물 및 이의 용도
WO2025132458A1 (en) 2023-12-18 2025-06-26 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors
WO2025132460A1 (en) 2023-12-18 2025-06-26 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60001229T2 (de) 1999-04-09 2003-10-30 Smithkline Beecham Corp., Philadelphia Triarylimidazole
AR029803A1 (es) 2000-02-21 2003-07-16 Smithkline Beecham Plc Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
EP1317450B1 (en) * 2000-09-15 2006-11-22 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
CA2423050A1 (en) 2000-09-20 2002-03-28 Ortho-Mcneil Pharmaceutical, Inc. Pyrazine derivatives as modulators of tyrosine kinases
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
JP2006503043A (ja) * 2002-09-10 2006-01-26 サイオス インク. TGFβ阻害剤
AU2004278382B2 (en) * 2003-09-30 2008-09-18 Amgen Inc. Vanilloid receptor ligands and their use in treatments
BRPI0714409A2 (pt) 2006-07-14 2013-03-12 Novartis Ag derivados de pirimidina como inibidores de alk-5
ES2375425T3 (es) 2007-07-26 2012-02-29 Novartis Ag Compuestos org�?nicos.
BRPI0817434A2 (pt) 2007-10-17 2015-06-16 Novartis Ag Composto orgânicos
AR070127A1 (es) 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
MX2010007604A (es) 2008-01-11 2010-08-02 Novartis Ag Pirimidinas como inhibidores de cinasa.
US8343966B2 (en) 2008-01-11 2013-01-01 Novartis Ag Organic compounds
EA201001687A1 (ru) 2008-04-29 2011-06-30 Новартис Аг Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 )
CN102596200A (zh) * 2009-11-07 2012-07-18 默克专利有限公司 作为TGF-β受体激酶抑制剂的杂芳基氨基喹啉类
DK2731949T3 (en) 2011-07-13 2018-06-14 Tiumbio Co Ltd 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS
HRP20201384T1 (hr) * 2014-01-01 2020-11-27 Medivation Technologies Llc Spojevi i postupci njihove upotrebe
US20200247812A1 (en) * 2018-07-10 2020-08-06 Integral Biosciences Private Limited Heterocyclic compounds and methods of use

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023533849A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)